ConserV Bioscience is a late-stage vaccine development company focused on advancing safe and effective vaccines that protect against endemic and emergent infectious diseases. We use a novel in silico proprietary platform to identify highly conserved regions of viral proteins that contain a high number of reactive T-cell epitopes with extensive HLA coverage.
These regions are then used as antigens and are delivered using the m...
ConserV Bioscience is a late-stage vaccine development company focused on advancing safe and effective vaccines that protect against endemic and emergent infectious diseases. We use a novel in silico proprietary platform to identify highly conserved regions of viral proteins that contain a high number of reactive T-cell epitopes with extensive HLA coverage.
These regions are then used as antigens and are delivered using the most appropriate method for the combination of antigens and the disease, for example, as synthetically-manufactured peptides or encoded in an mRNA construct encased in lipid nanoparticles or nanolipoprotein particles.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.